EWS
REGN icon

Evergreen Wealth Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Evergreen Wealth Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-430
Closed -$452K – 114
2024
Q3 		$452K Sell
430
-146
-25% -$162K 0.31% 66
2024
Q2 		$605K Sell
576
-37
-6% -$35.9K 0.43% 49
2024
Q1 		$590K Sell
613
-50
-8% -$47.5K 0.44% 50
2023
Q4 		$582K Sell
663
-2
-0.3% -$1.65K 0.5% 48
2023
Q3 		$547K Sell
665
-15
-2% -$11.8K 0.55% 49
2023
Q2 		$489K Buy
680
+70
+11% +$54K 0.49% 66
2023
Q1 		$501K Sell
610
-32
-5% -$24.1K 0.58% 58
2022
Q4 		$463K Buy
642
+62
+11% +$45.7K 0.61% 55
2022
Q3 		$400K Buy
+580
New +$365K 0.57% 59

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return